In this work, we discovered TB206-001, a potent, selective, and tumor-suppressing antibody antagonist of hA2AR. We contend that inhibiting A2AR with TB206-001 can restore immune responses in immunosuppressive tumor microenvironments (S1 Fig). This evidence concerns the gene ADORA2A and neoplasm.